FDA Inspection
Michael M. Dao, M.D.Michael M. Dao, M.D. – FDA Inspection, Jan 18, 2013
Record Details
This FDA Inspection record concerns Michael M. Dao, M.D., with an inspection on January 18, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Michael M. Dao, M.D.
- Inspection Date
- January 18, 2013
- Product Type
- Drugs
View Company Profile
ID · ca1fa470-9690-464a-a68c-4d73904dde97
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 814431
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.62(c)Record retention
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Michael M. Dao, M.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 18, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 16, 2014 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Michael M. Dao, M.D.
- FDA Inspection 1103474 - 2019-07-18
- FDA Inspection 881983 - 2014-05-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.